The normal gastric microflora and Helicobacter pylori; before, during and after treatment with omeprazole and amoxycillin

Clinical Microbiology and Infection

Volumn 4, Issue 6, 1998, Pages 308-315

  Adamsson, Inger ^a   Edlund, Charlotta ^a   Seensalu, Rein ^a   Sjöstedt, Svante ^a   Nord, Carl Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

AP PCR; Commensal microflora; Helicobacter pylori

Indexed keywords

AMOXICILLIN; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; BACTERIAL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPEPSIA; FEMALE; GASTROINTESTINAL BIOPSY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE FLORA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; SALIVA; STOMACH ANTRUM; TIME; TOOTH PLAQUE;

EID: 0031903772     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00064.x     Document Type: Article

References (22)

1. Nord CE, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. AmJ Med 1984; 76: 99-105.
2. Brismar B, Edlund C, Nord CE. Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. Eur J Chn Microbiol Infect Dis 1993; 12: 714-19.
3. Hill MJ. The normal gut bacterial flora. In Hill MJ, ed. The normal gut bacterial flora. London: Taylor & Francis, 1995: 3-17.
4. Borriello SP, Reed PJ, Dolby JM, Barclay FE, Webster ADB. Microbial and metabolic profile of achlorhydric stomach: comparison of pernicious anaemia and hypogammaglobulinaemia. J Clin Pathol 1985; 38: 946-53.
5. Sjöstedt S, Kager L, Veress B, Nord CE. Campylobacter pylori in relation to other aerobic and anaerobic microorganisms in patients with gastric diseases. Microb Ecol Health Dis 1989; 2: 107-14.
6. Banatvala N, Romero Lopez C, Owen RJ, et al. Use of the polymerase chain reaction to detect Helicobaaer pylori in the dental plaque of healthy and symptomatic individuals. Microb Ecol Health Dis 1994; 7: 1-8.
7. Hultén K, Han SW, Enroth H, et al. Helicobacter in the drinking water in Peru. Gastroenterology 1996; 110: 1031-5.
8. West AP, Millar MR, Tompkins DS. Effects of physical environment on survival of Helicobacter pylori. J Clin Pathol 1992; 45: 228-31.
9. Maton PN. Omeprazole. N Engl J Med 1991; 324: 965-75.
10. Heimdahl A, Nord CE. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis 1979; 11: 233-42.
11. Nord CE. Studies on the ecological impact of antibiotics. Eur J Clin Microbiol Infect Dis 1990; 9: 517-18.
12. Stark CA, Adamsson I, Edlund C, et al. Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. J Antimicrob Chemother 1996; 38: 927-39.
13. Weiss J, Mecca J, da Silva E, Gassner D. Comparison of PCR and other diagnostic techniques for detection of Helicobacter pylori infection in dyspeptic patients. J Clin Microbiol 1994; 32: 1663-7.
14. Hultén K, Gibreel A, Sköld O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 1997; 41: 2550-3.
15. Wilson K. Preparation of genomic DNA from bacteria. In Ausubel FM, Brent R, Kingston RE, et al, eds. Current protocols in molecular biology. New York: Wiley, 1987: Unit 2.4.1.
16. Edlund C, Nord CE. Ecological impact of antimicrobial agents on human intestinal microflora. Alpe Adria Microbiol J 1993; 3: 137-64.
17. Cooreman MP, Krausgrill P, Hengels KJ. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother 1993; 37: 1506-9.
18. Gorbach SL. Intestinal microflora Gastroenterology 1971; 60: 1110-29.
19. Walsh JH, Peterson WL. Drug treatment: the treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995; 15: 984-91.
20. Leigh DA. Pharmacology and toxicological studies with amoxycillin, talampicillin and ampicillin and a clinical trial of parenteral amoxycillin in serious hospital infections. Drug Exp Clin Res 1979; 5: 129-39.
21. Gipponi M, Sciutto C, Accornero L. Assessing modifications of the intestinal bacterial flora in patients on long-term oral treatment with bacampicillin or amoxycillin: a random study. Chemioterapia 1985; 4: 208-15.
22. Nakao M, Tada M, Tsuchimori K, Uekata M. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1995; 14: 391-9.